Edition:
United Kingdom

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

1.25USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$1.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,627
52-wk High
$5.99
52-wk Low
$1.03

Latest Key Developments (Source: Significant Developments)

Bioblast Pharma Says Effective July 31, Chairman & CEO Will Step Down
Thursday, 26 Jul 2018 

July 26 (Reuters) - Bioblast Pharma Ltd ::BIOBLAST PHARMA - DETERMINED IT IS IN BEST INTEREST OF CO'S SHAREHOLDERS TO FURTHER REDUCE EXPENSES.BIOBLAST PHARMA LTD - EFFECTIVE JULY 31, FREDRIC PRICE WILL BE STEPPING DOWN AS CHAIRMAN & CEO.BIOBLAST PHARMA - FREDRIC PRICE WILL BE LEAVING BOARD, ALONG WITH 4 INDEPENDENT MEMBERS OF BOARD.BIOBLAST PHARMA LTD - WARREN WASIEWSKI, STEPPED DOWN AS COMPANY'S CHIEF MEDICAL OFFICER.BIOBLAST PHARMA LTD - DALIA MEGIDDO, COMPANY CO-FOUNDER, WILL REMAIN ON BOARD AND WILL SERVE AS CEO AND CMO.BIOBLAST PHARMA - WORKING DILIGENTLY TO FIND COMMERCIAL PARTNER FOR INVESTIGATIONAL PROPRIETARY INTRAVENOUS FORM OF TREHALOSE 90 MG/ML SOLUTION.BIOBLAST PHARMA LTD - WORKING DILIGENTLY TO ENTER INTO A MERGER AGREEMENT WITH A THIRD PARTY.  Full Article

Bioblast Pharma reports Q3 loss per share $0.32
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Bioblast Pharma Ltd :Bioblast Pharma reports third quarter 2017 financial results.Q3 loss per share $0.32.  Full Article